Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial.
Comparison of Vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week randomized trial